Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Andersohn

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|July 21, 2009
Effect on survival of whole-body CT during trauma resuscitationFrank Andersohn
Cardiovascular Drugs and Therapy|April 4, 2007
Cerebrovascular events after discontinuation of rofecoxib treatmentFrank Andersohn
European Journal of Clinical Pharmacology|November 25, 2006
Contraindication labelling changes in the United States and GermanyEdeltraut Garbe, Frank Andersohn
Movement Disorders : Official Journal of the Movement Disorder Society|January 27, 2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonistsFrank Andersohn, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|November 5, 2015
Characteristics and external validity of the German Health Risk Institute (HRI) DatabaseFrank Andersohn, Jochen Walker
Oncology|March 18, 2011
Is guideline adherence the key to increased survival in patients with breast cancer?Falk Hoffmann, Frank Andersohn
Archives of Internal Medicine|September 30, 2009
The healthy adherer effectFrank Andersohn, Stefan N Willich
BMJ (Clinical Research Ed.)|February 10, 2010
Interaction of serotonin reuptake inhibitors with tamoxifenFrank Andersohn, Stefan N Willich
Pharmacoepidemiology and Drug Safety|July 24, 2012
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)Niklas Schmedt, Frank Andersohn, Edeltraut Garbe
Bone|November 3, 2007
Re: Biphasic fracture risk in diabetes: a population-based studyFrank Andersohn, Samy Suissa, Edeltraut Garbe
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|July 21, 2009
Effect on survival of whole-body CT during trauma resuscitationFrank Andersohn
Cardiovascular Drugs and Therapy|April 4, 2007
Cerebrovascular events after discontinuation of rofecoxib treatmentFrank Andersohn
European Journal of Clinical Pharmacology|November 25, 2006
Contraindication labelling changes in the United States and GermanyEdeltraut Garbe, Frank Andersohn
Movement Disorders : Official Journal of the Movement Disorder Society|January 27, 2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonistsFrank Andersohn, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|November 5, 2015
Characteristics and external validity of the German Health Risk Institute (HRI) DatabaseFrank Andersohn, Jochen Walker
Oncology|March 18, 2011
Is guideline adherence the key to increased survival in patients with breast cancer?Falk Hoffmann, Frank Andersohn
Archives of Internal Medicine|September 30, 2009
The healthy adherer effectFrank Andersohn, Stefan N Willich
BMJ (Clinical Research Ed.)|February 10, 2010
Interaction of serotonin reuptake inhibitors with tamoxifenFrank Andersohn, Stefan N Willich
Pharmacoepidemiology and Drug Safety|July 24, 2012
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)Niklas Schmedt, Frank Andersohn, Edeltraut Garbe
Bone|November 3, 2007
Re: Biphasic fracture risk in diabetes: a population-based studyFrank Andersohn, Samy Suissa, Edeltraut Garbe
Pageof 6